期刊文献+

bFGF对多孔高密度聚乙烯-软骨复合支架血管化的实验研究 被引量:1

Experimental study of bFGF on porous high density polyethylene-cartilage scaffold vascularization
原文传递
导出
摘要 目的观察碱性成纤维细胞生长因子(bFGF)在多孔高密度聚乙烯(Medpor)-软骨复合支架血管化中的应用效果,探讨其使用意义。方法构建兔耳软骨与Medpor复合支架模型,植于兔背部皮下,将实验动物分成2组:耳软骨与Medpor材料直接连接组(A组);耳软骨与Medpor材料直接连接后,bFGF处理组(术中及术后2d,每日局部注射bFGF100ng,B组);置入后第3、7、14、28天后取出复合支架,行大体和组织学观察,免疫组织化学法(SABC法),检测Medpor片边缘及内部CD34表达,并行微血管密度(MVD)计数。结果B组术后早期Medpor材料周边纤维组织增生及血管化较A组明显,但后期血管化程度与A组无明显差异。结论术后早期应用bFGF对复合支架的纤维血管化过程中起到明显的促进作用,加强Medpor与软骨片的连接,增强复合支架的稳定性及抗感染力。 Objective To observe the application effect of basic fibroblast growth factor (bFGF) in the medpor-cartilage scaffold vascularization, and explore its significance. Methods Build rabbit ear cartilage with Medpor bracket model, implanted in rabbits subcutaneously, and the animals were divided into two groups : the ear cartilage and Medpor material directly connected group ( Group A ) ; the ear cartilage directly connected with medpor, and the scaffold was pretreated with bFGF( 100 ng/d×3 d, Group B). At the 3, 7, 14, 28 clays after implantation, remove the composite scaffold for gross and histological observation, immuno- histochemical method (SABC method ) detection of CD34 expression in composite scaffolds and parallel mi- crovessel density (MVD) count. Results Proliferation of fibrous tissue and vascularization in the early postop- erative Group B than Group A was significantly, but no significant difference in the late vascularization with group A. Conclusion Early postoperative application of bFGF play a significant role in promoting for compos- ite scaffolds fibrovascular process, and strengthen the connection between the Medpor material and cartilage piece, enhance the stability of the composite scaffold and anti-infectious.
出处 《中国美容整形外科杂志》 CAS 2013年第10期621-625,共5页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 碱性成纤维细胞生长因子 多孔高密度聚乙烯 鼻尖成形术 血管化 bFGF Porous high-density polyethylene Nasal tip plasty Vascularization
  • 相关文献

参考文献18

  • 1Uysal A, Ozbek S, Ozcan M. Comparison of the biological activi- ties of high-density porous polyethylene implants and oxidized re- generated cellulose-wrapped diced cartilage grafts [ J ]. Plast Re- constr Surg, 2003,112(2) :540-546.
  • 2Duman H, Deveci M, Uygur F, et al. Reconstruction of contour and anterior wall defects of frontal bone with a porous polyethylene implant[ J ]. J Craniomaxillofac Surg, 1999,27 (5) :298-301.
  • 3Frodel JL, Lee S. The use of high-density polyethylene implants in facial deformities[ J]. Arch Otolaryngol Head Neck Surg, 1998, 124( 11 ) : 1219-1223.
  • 4Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases [ J ]. Ophthalmology, 1992, 99(5) :831-836.
  • 5Yaremchuk MJ. Facial skeletal reconstruction using porous poly- ethylene implants [ J ]. Plast Reconstr Surg, 2003,111 ( 6 ) : 1818- 1827.
  • 6Gurlek A, Firat C, Aydogan H, et al. Augmentation mentoplasty with diced high-density porous polyethylene [ J ]. Plast Reconstr Surg, 2007,119(2) :6844591.
  • 7Skouras A, Skouras G, Karypidis D, et al. The use of Medpor al-loplastic material in rhinoplasty: experience and outcomes [ J ]. J Plast Reconstr Aesthet Surg, 2012,65( 1 ) :35-42.
  • 8Kim YH, Kim B J, Jang TY. Use of porous high-density polyethy- lene (Medpor) for spreader or extended septal graft in rhinoplasty: aesthetics, functional outcomes, and long-term complications [ J ]. Ann Plast Surg, 2011,67(5) :464-468.
  • 9Reiffel AJ, Cross KJ, Spinelli HM. Nasal spreader grafts: a com- parison of medpor to autologous tissue reconstruction [ J ]. Ann Plast Surg, 2011,66( 1 ) :24-28.
  • 10Sajjadian A, Naghshineh N, Rubinstein R. Current status of grafts and implants in rhinoplasty: Part Ⅱ. Homologous grafts and allogenic implants [ J]. Plast Reconstr Surg, 2010, 125 (3) :99e-109e.

二级参考文献18

  • 1邹萍,向建平,陈智超,李崇渔.急性髓系白血病细胞CD_(34)抗原表达的研究Ⅰ表达特点和临床意义[J].中华血液学杂志,1994,15(7):339-341. 被引量:28
  • 2操州虹,刘秀芳,王辨明.不同病期慢性粒细胞白血病CD_(34)阳性细胞的临床意义[J].中华血液学杂志,1996,17(1):10-12. 被引量:3
  • 3Ichinoe M, Mikami T, Shiraishi H, et al. High microvascular density is correlated with high VEGF, iNOS and COX-2 expression in penetrating growth-type early gastric carcinomas [ J ]. Histopathology, 2004;45(6) :612 -618.
  • 4Kirmaz C, Ozbilgin K, Yuksel H, et al. Increased expression of anglogenic markers in patients with seasonal allergic rhinitis[J]. Eur Cytokine Netw, 2004;15(4) :317 -322.
  • 5Hao XP, Willis JE,Pretlow TG, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions [ J ].Cancer Res, 2000 ;60 : 18 - 20.
  • 6Takahashi Y, Cleary KR, Mai M, et al. Significance of Vesselcount and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer [ J]. Cancer Res, 1996 ; 2 : 1679 - 1684.
  • 7Chen J, De S, Brainard J, et al. Metastatic properties of prostate cancer cells are controlled by VEGF [ J ]. Cell Commun Adhes,2004;11(1):1 -11.
  • 8Bergsland EK. Vascular endothelial growth factor as a therapeutic target in cancer [J]. Am J Health Syst Pharm,2004;61 (21 Suppl 5) :S4 -S11.
  • 9Ishikawa M, Kitayama J, Kazama S, et al. Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma[J]. World J Surg 0ncol,2005;3(1) :2.
  • 10Raspollini MR, Amunni G, Villanucci A, et al. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma[J]. Int J Gynecol Cancer, 2004;14(5) :815 -823.

共引文献45

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部